Buy Crypto Markets Spot FuturesGOLD Earn Event Center

bioAffinity Technologies, Inc. (BIAF)

NASDAQ

$3.55

$-0.43

(-10.75%)

bioAffinity Technologies, Inc. (BIAF) Live Price Chart

Page last updated: 2026-03-31 00:01:00

Key Market Data

Market Cap	$15.97M
Open	$3.89
High	$466.50
Low	$0.69
Previous Close	$4.00
Price Change	$-0.43
Percentage Change	-10.75%
Volume	1M

bioAffinity Technologies, Inc. (BIAF) Stock Price Today

bioAffinity Technologies, Inc. (BIAF) is currently trading at $3.55 as of 2026-03-31 00:01:00, reflecting a -10.75% move ($-0.43) from the previous close.

In the short term, the stock has returned +234.91% over the past four weeks. Over the last 12 months, bioAffinity Technologies, Inc. has recorded a -54.49% price change, indicating a weak performance relative to the broader market.

bioAffinity Technologies, Inc. (BIAF) 7-Day Stock Price Changes

Over the past seven days, bioAffinity Technologies, Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. During this period, the stock moved from its previous closing price of $4.16 to the latest recorded price of $3.55, reflecting an intraday change of -10.75%. Daily movements highlight shifts in trading volume (1,283,872), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BIAF has delivered a +234.91% return over the past month and a -54.49% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy bioAffinity Technologies, Inc. (BIAF)

You can buy and trade BIAF on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for BIAF and Execute Your Trade

Open the trading page, enter BIAF in the search bar, select the amount of BIAF you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is bioAffinity Technologies, Inc. (BIAF)?

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

bioAffinity Technologies, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	57
Sector	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Website	https://www.bioaffinitytech.com

Frequently Asked Questions (FAQ)

1.What is the current share price of bioAffinity Technologies, Inc.?

The latest trading price for bioAffinity Technologies, Inc. (Common Stock) is $ 3.55, compared with a previous closing price of $ 4.00. That means the stock has moved -10.75% so far today. Intraday price updates and recent trading activity for BIAF can be tracked on the live chart and quote section on this page.

2.Is bioAffinity Technologies, Inc. stock going up or down?

Looking at recent performances, BIAF has returned +234.91% over the past month, +27.70% over the last six months and -54.49% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for bioAffinity Technologies, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does BIAF currently sit relative to its 52-week high and low?

In the most recent 52-week period, bioAffinity Technologies, Inc. has traded between a low of $ 0.69 and a high of $ 46.53. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether BIAF is currently nearer the top or the bottom of its one-year trading band.

4.How is bioAffinity Technologies, Inc. classified by sector and industry?

bioAffinity Technologies, Inc. is classified in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. In practice, this means bioAffinity Technologies, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing BIAF’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector could influence bioAffinity Technologies, Inc.’s performance.

5.Where is bioAffinity Technologies, Inc. listed and how large is it by market value?

bioAffinity Technologies, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 15.97M, the company is classified as a Small-cap stock. Market cap gives a quick sense of bioAffinity Technologies, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does BIAF's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -3.31 summarises how much profit bioAffinity Technologies, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track bioAffinity Technologies, Inc.'s financial performance over time?

To follow bioAffinity Technologies, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BIAF is performing and how the market is responding.

8.When is bioAffinity Technologies, Inc. expected to report earnings?

bioAffinity Technologies, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BIAF, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in bioAffinity Technologies, Inc.'s earnings reports?

bioAffinity Technologies, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BIAF is meeting, beating or missing expectations.

10.How can I stay informed about bioAffinity Technologies, Inc.'s results and guidance?

You can stay up to date on bioAffinity Technologies, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BIAF on this page helps you see how new information is being reflected in the stock.

11.Does bioAffinity Technologies, Inc. pay a regular cash dividend to its shareholders?

bioAffinity Technologies, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BIAF's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for BIAF?

Based on the latest earnings data, BIAF has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether bioAffinity Technologies, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings bioAffinity Technologies, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is bioAffinity Technologies, Inc.?

bioAffinity Technologies, Inc. is a publicly traded company in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is BIAF valued in terms of P/E ratio and EPS?

bioAffinity Technologies, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -3.31. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of bioAffinity Technologies, Inc.'s earnings. Comparing BIAF's P/E and EPS to those of other SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as bioAffinity Technologies, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Amazon.Com Inc.

AMZN

Applied Digital Corporation

DPZ

Top Gainers

Browse today's leading gainers in the US stock market

Astrotech Corporation (DE)

ASTC

American Vanguard Corporation

AVD

Bullfrog AI Holdings, Inc.

BFRG

PMGC Holdings Inc.

ELAB

Greenland Energy Company

GLND

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

BIAF-to-USD Calculator

Amount

BIAF

USD

1 BIAF = 3.55 USD